JP2010536903A - 酵母を含む医薬製品 - Google Patents

酵母を含む医薬製品 Download PDF

Info

Publication number
JP2010536903A
JP2010536903A JP2010522231A JP2010522231A JP2010536903A JP 2010536903 A JP2010536903 A JP 2010536903A JP 2010522231 A JP2010522231 A JP 2010522231A JP 2010522231 A JP2010522231 A JP 2010522231A JP 2010536903 A JP2010536903 A JP 2010536903A
Authority
JP
Japan
Prior art keywords
pharmaceutical product
yeast
product according
ingredient
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010522231A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010536903A5 (enExample
Inventor
アスムッセン，ボードー
シラー，クリスティアン
ヴァイトシーズ，ヴェルナー
ガルバッツ，グレゴール
アー． オマール−アダム，マームド
ナーゲル，シュテファン
Original Assignee
エルテーエス ローマン テラピー−ジステーメ アーゲー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40299087&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP2010536903(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by エルテーエス ローマン テラピー−ジステーメ アーゲー filed Critical エルテーエス ローマン テラピー−ジステーメ アーゲー
Publication of JP2010536903A publication Critical patent/JP2010536903A/ja
Publication of JP2010536903A5 publication Critical patent/JP2010536903A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2010522231A 2007-09-01 2008-08-21 酵母を含む医薬製品 Pending JP2010536903A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007041588A DE102007041588A1 (de) 2007-09-01 2007-09-01 Arzneimittel mit Hefe
PCT/EP2008/006897 WO2009052888A2 (de) 2007-09-01 2008-08-21 Arzneimittel mit hefe

Publications (2)

Publication Number Publication Date
JP2010536903A true JP2010536903A (ja) 2010-12-02
JP2010536903A5 JP2010536903A5 (enExample) 2011-04-21

Family

ID=40299087

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010522231A Pending JP2010536903A (ja) 2007-09-01 2008-08-21 酵母を含む医薬製品

Country Status (14)

Country Link
US (1) US20120027856A1 (enExample)
EP (1) EP2180885B1 (enExample)
JP (1) JP2010536903A (enExample)
KR (1) KR101259673B1 (enExample)
CN (1) CN101795676B (enExample)
AU (1) AU2008316051A1 (enExample)
CA (1) CA2698327C (enExample)
DE (1) DE102007041588A1 (enExample)
ES (1) ES2456267T3 (enExample)
MX (1) MX2010002167A (enExample)
NZ (1) NZ584233A (enExample)
RU (1) RU2452473C2 (enExample)
WO (1) WO2009052888A2 (enExample)
ZA (1) ZA201000853B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019513022A (ja) * 2016-04-01 2019-05-23 アクセス ビジネス グループ インターナショナル リミテッド ライアビリティ カンパニー ビタミンｂの二重層錠剤及びその製造方法

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009027938A1 (de) * 2009-07-22 2011-01-27 Universität Greifswald Orales therapeutisches System und seine Verwendung
WO2013159068A1 (en) * 2012-04-20 2013-10-24 Enmotus Inc. Storage system with data management mechanism and method of operation thereof
CN106456681B (zh) * 2014-06-10 2019-11-22 狮王株式会社 含有清酒酵母的片剂

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6244248A (ja) * 1985-08-16 1987-02-26 アルザ・コ−ポレ−シヨン 家畜用デイスペンサ
JP2004526774A (ja) * 2001-04-25 2004-09-02 エルテーエス ローマン テラピー−ジステーメ アーゲー 粘膜粘着性活性物質賦形剤の放出用の胃液耐性デバイス、およびこの胃液耐性デバイスの製造方法
JP2005537233A (ja) * 2002-06-04 2005-12-08 エルテーエス ローマン テラピー−ジステーメ アーゲー 活性物質放出のためのフィルム成形された溶解可能な製剤およびこれらの製造方法
JP2006506362A (ja) * 2002-10-11 2006-02-23 デポメド・ディベロップメント・リミテッド 胃内保持型レボドパデリバリー形態

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE145551T1 (de) 1989-10-02 1996-12-15 Cima Labs Inc Brausedosisform sowie verfahren zu deren verabreichung
DE60005819T2 (de) * 1999-06-14 2004-05-06 Cosmo S.P.A. Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
GB0114069D0 (en) * 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
WO2002102415A1 (en) * 2001-06-18 2002-12-27 Blue Cross Laboratories Limited Gastric floating system
WO2003000112A2 (en) 2001-06-20 2003-01-03 The Governement Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of ribonuclease l in diagnosis of cancer
US6835397B2 (en) * 2002-12-23 2004-12-28 Balchem Corporation Controlled release encapsulated bioactive substances
US20060003003A1 (en) 2004-06-28 2006-01-05 Bakker Johan A Oral sustained release formulation of tedisamil with gastric retention properties
DE102004042139B4 (de) 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
US7799328B2 (en) * 2004-12-23 2010-09-21 Biocodex Method for treating weight loss in patients suffering from inflammatory bowel diseases
AU2008273095A1 (en) * 2007-07-12 2009-01-15 Dsm Ip Assets B.V. Nitrate reduction by a probiotic in the presence of a heme

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6244248A (ja) * 1985-08-16 1987-02-26 アルザ・コ−ポレ−シヨン 家畜用デイスペンサ
JP2004526774A (ja) * 2001-04-25 2004-09-02 エルテーエス ローマン テラピー−ジステーメ アーゲー 粘膜粘着性活性物質賦形剤の放出用の胃液耐性デバイス、およびこの胃液耐性デバイスの製造方法
JP2005537233A (ja) * 2002-06-04 2005-12-08 エルテーエス ローマン テラピー−ジステーメ アーゲー 活性物質放出のためのフィルム成形された溶解可能な製剤およびこれらの製造方法
JP2006506362A (ja) * 2002-10-11 2006-02-23 デポメド・ディベロップメント・リミテッド 胃内保持型レボドパデリバリー形態

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019513022A (ja) * 2016-04-01 2019-05-23 アクセス ビジネス グループ インターナショナル リミテッド ライアビリティ カンパニー ビタミンｂの二重層錠剤及びその製造方法
US11291683B2 (en) 2016-04-01 2022-04-05 Access Business Group International Llc Bilayer tablets of B vitamins and process for preparing the same

Also Published As

Publication number Publication date
CN101795676B (zh) 2012-11-28
RU2452473C2 (ru) 2012-06-10
US20120027856A1 (en) 2012-02-02
EP2180885B1 (de) 2014-01-29
RU2010109523A (ru) 2011-10-20
CN101795676A (zh) 2010-08-04
CA2698327A1 (en) 2009-04-30
EP2180885A2 (de) 2010-05-05
WO2009052888A2 (de) 2009-04-30
WO2009052888A3 (de) 2009-10-15
KR101259673B1 (ko) 2013-05-06
CA2698327C (en) 2013-04-30
ES2456267T3 (es) 2014-04-21
KR20100059880A (ko) 2010-06-04
DE102007041588A1 (de) 2009-03-05
AU2008316051A1 (en) 2009-04-30
MX2010002167A (es) 2010-04-29
NZ584233A (en) 2012-02-24
ZA201000853B (en) 2010-10-27

Similar Documents

Publication Publication Date Title
CN111405895B (zh) 一种控释药物组合物及其制备方法
US20180008539A1 (en) Gastroretentive extended release suspension compositions
CN100563638C (zh) 硝苯地平控释片及其制备方法
EP2765998A1 (en) A gastroretentive dosage system and process of preparation thereof
CN102018682A (zh) 一种渗透泵型控释片及其制备方法
CA2698327C (en) Pharmaceutical product comprising yeast
CN101732276A (zh) 一种单硝酸异山梨酯的片剂
US20030143272A1 (en) Pharmaceutical tablet and process for making thereof
CN106511293A (zh) 含有达方吡啶的缓释口服制剂及其用途
CN101642444B (zh) 单硝酸异山梨酯双速渗透泵型控释制剂及其制备方法
CN102764243B (zh) 一种阿司匹林脉冲释放微丸和其制剂及其制备方法
CN102920707A (zh) 一种复方抗结核制剂的制备工艺
CN102727496A (zh) 一种复方抗结核药口服固体制剂及其制备方法
CN1216597C (zh) 胃漂浮型脉冲释放胶囊
CN111494328A (zh) 一种含阿卡波糖和达格列净的渗透泵片及其制备方法
CN101269056B (zh) 一种美托洛尔盐类口服脉冲微丸制剂
CN102349880A (zh) 伊拉地平控释片及其制备方法
EP4299056A1 (en) Sleep regulation tablet allowing release by stage and preparation method therefor
CN100536838C (zh) 一种盐酸坦洛新控释片制剂及其制备方法
KR20080110876A (ko) 박동성 방출을 위한 경구용 제약 코팅 조성물
US20060280788A1 (en) Delivery and formulations of mast cell stabilizers
US20100143472A1 (en) Osmotic form for controlled release of active principles
CN101869711A (zh) 含有利尿剂类降血压药物和双胍类降糖药物的药物组合物及其用途
CN110325192A (zh) 具有抗hiv活性的药物组合物
Supe et al. OSMOTIC CONTROLLED DRUG DELIVERY SYSTEM: A NOVEL APPROACH FOR DIABETIC CARE

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110301

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110301

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20130124

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130129

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130430

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130509

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130524

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20131008

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140108

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140116

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140207

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140311

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140609

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140616

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20141202